1.
Nanoscale
; 13(13): 6410-6416, 2021 Apr 07.
Article
in English
| MEDLINE | ID: covidwho-1189295
ABSTRACT
The control of COVID-19 across the world requires the formation of a range of interventions including vaccines to elicit an immune response and immunomodulatory or antiviral therapeutics. Here, we demonstrate the nanoparticle formulation of a highly insoluble drug compound, niclosamide, with known anti SARS-CoV-2 activity as a cheap and scalable long-acting injectable antiviral candidate.